左卡尼汀联合生脉注射液对维持性血液透析低血压心脏功能的影响

doi:10.3969/j.issn.1000-8535.2022.04.017

摘要/Abstract

摘要： 目的探讨左卡尼汀联合生脉注射液对维持性血液透析低血压心脏功能的影响。方法选取我院2016年1月—2020年2月收治的维持性血液透析反复低血压患者120例,随机分为对照组(n=40)、左卡尼汀组(n=40)和联合组(n=40)。3组均采用常规治疗,左卡尼汀组加用左卡尼汀,联合组加用左卡尼汀联合生脉注射液。分析3组治疗前后低血压发生率、血压指标、心肌酶谱、心肌梗死定量指标及超声心动图指标变化。收集3组治疗过程中发生不良反应情况。结果联合组低血压发生率低于对照组和左卡尼汀组(P＜0.05);联合组治疗后透析中最低收缩压、透析中平均动脉压、透析后收缩压、透析后平均动脉压均高于对照组和左卡尼汀组(P＜0.05);联合组治疗后心肌谱酶、心肌梗死定量指标均低于对照组及左卡尼汀组(P＜0.05);3组治疗前后肺动脉收缩压、右室壁舒张末期厚度、右室舒张末期内径、左室舒张末期内径、右室收缩末期面积、右室舒张末期面积差异无统计学意义(P＞0.05);联合组治疗后左室射血分数高于对照组和左卡尼汀组(P＜0.05);3组不良反应发生率差异无统计学意义(P＞0.05)。结论左卡尼汀联合生脉注射液可降低维持性血液透析患者低血压的发生率,改善患者心功能,具有较好的疗效及安全性。

关键词: 左卡尼汀, 生脉注射液, 血液透析, 低血压, 心脏功能

Abstract: Objective To investigate the effect of L-carnitine combined with Shengmai Injection on cardiac function in patients with maintenance hemodialysis hypotension. Methods A total of 120 maintenance hemodialysis patients with recurrent hypotension in our hospital from January 2016 to February 2020 were randomly divided into control group (n=40), L-carnitine group (n=40) and combination group (n=40). The three groups were treated with conventional treatment, L-carnitine group was added with L-carnitine, and the combination group was given levocarnitine combined with Shengmai Injection. The incidence of hypotension, blood pressure index, myocardial enzyme spectrum, quantitative index of myocardial infarction and echocardiography index were obtained and analyzed before and after treatment. The adverse reactions in the three groups were collected. Results The incidence of hypotension in combination group was lower than that in control group and L-carnitine group (P<0.05). After treatment, the minimum systolic blood pressure, mean arterial pressure during dialysis, systolic blood pressure after dialysis and mean arterial pressure after dialysis in the combination group were higher than those in the control group and L-carnitine group (P<0.05). After treatment, the myocardial spectrum enzyme and myocardial infarction quantitative indexes in the combination group were lower than those in the control group and L-carnitine group (P<0.05). There were no significant differences in pulmonary artery systolic pressure, diastolic right ventricular wall thickness, diastolic right ventricular width, diastolic left ventricular width, systolic right ventricular area and diastolic right ventricular area among the three groups before and after treatment (P>0.05). The left ventricular ejection fraction of the combination group was higher than that of the control group and L-carnitine group (P<0.05). There was no significant difference in the incidence of adverse reactions among the three groups (P>0.05). Conclusions L-carnitine combined with Shengmai Injection could reduce the incidence of hypotension in maintenance hemodialysis patients, improve the cardiac function, with good efficacy and safety.

Key words: L-carnitine, Shengmai Injection, hemodialysis, hypotension, cardiac function

龚廷信. 左卡尼汀联合生脉注射液对维持性血液透析低血压心脏功能的影响[J]. 广州医药, 2022, 53(4): 73-77.

GONG Tingxin. Effect of L-carnitine combined with Shengmai Injection on cardiac function in patients with maintenance hemodialysis hypotension[J]. Guangzhou Medical Journal, 2022, 53(4): 73-77.

参考文献

[1] 孟庆庆,翟小琳,袁毅, 等.维持性血液透析患者镁代谢紊乱及冠状动脉钙化的相关影响因素研究[J].中国中西医结合肾病杂志,2019,20(7):623-625.
[2] 黄敏, 杨春琴. 维持性血液透析患者心血管疾病死亡的危险因素分析[J]. 中国药物与临床, 2018, 18(1):105-107.
[3] 冀旭,孟宇,薛泮宏,等.左卡尼汀联合超纯透析对维持性血液透析患者血管内皮细胞功能的影响[J].内科急危重症杂志,2018,24(5):425-427.
[4] 卢芬萍,苏宁,征宗梅,等.生脉注射液联合常规治疗方案治疗急性心肌梗死的Meta分析及系统评价[J].中草药,2018,49(5):1201-1210.
[5] 冯汀兰,赵宇芳,刘建华.生脉注射液对休克复苏的影响[J].山西中医学院学报,2012,13(5):35-37.
[6] 汪知玉, 陈孜瑾, 陈晓农. 透析中低血压诊断标准及其与心血管并发症和预后相关性的研究进展[J]. 中华肾脏病杂志, 2017, 33(8):627-631.
[7] 张园,陈晓岚,范亚平,等.维持性血液透析患者透析前血浆渗透压与血液透析中低血压的关系[J].江苏医药,2018,44(1):58-61.
[8] 濮红梅, 冯锦红, 刘秉成, 等. 环磷腺苷葡胺联合低温可调钠透析治疗透析中低血压的临床疗效研究[J]. 中国全科医学, 2018, 21(15):48-51.
[9] 朱纯, 徐树人, 金玫萍,等. 左卡尼汀联合生脉注射液改善血液透析相关性低血压临床观察[J]. 临床肾脏病杂志, 2013, 13(1):38-40.
[10] ZHANG S H, TIAN M, SONG H Q, et al. Effects of L-carnitine on reproductive performance, milk composition, placental development and IGF concentrations in blood plasma and placental chorions in sows[J]. Arch Anim Nutr, 2018, 72(4):261-274.
[11] 胡跃玲, 陈明. 左卡尼汀在心血管疾病中的研究进展[J]. 心血管病学进展, 2018, 205(3):128-131.
[12] LEA K, BRANIMIR K, BOJAN J, et al. The unexpected effects of L-carnitine supplementation on lipid metabolism in hemodialysis patients[J]. Kidney Blood Press Res, 2018, 43(4):1113-1120.
[13] 黄明剑,潘朝锌,庞延,等.急性心肌梗死急诊冠状动脉介入后应用丹参多酚酸盐联合生脉注射液治疗的临床疗效观察[J].中西医结合心脑血管病杂志,2019,17(15):2241-2244.
[14] 王建秋. 中西医结合治疗高龄维持性血液透析低血压的临床观察[J]. 航空航天医学杂志, 2018, 29(7):850-851.
[15] 郭琼,张建起,石蕊.生脉注射液联合西医常规治疗全身炎症反应综合征的疗效及对血管活性递质的影响[J].现代中西医结合杂志,2018,27(7):743-746.